TORONTO — Health Canada has authorized updated COVID-19 vaccines by Pfizer and BioNTech and by Moderna for use this ...

Health Canada announced it has approved a new vaccine made by Pfizer Canada and BioNTech for the fall of 2025. According to Canada’s health agency, the vaccine is an updated version of a COMIRNATY ...

One of the highest yields you can get right now is from Pfizer ( PFE 0.90%). The healthcare giant offers a yield of 6.8%, ...

Pfizer's Canadian unit and BioNTech said they have received approval in Canada for their updated Comirnaty Covid-19 vaccine. The companies said Monday the updated vaccine targets the Omicron LP.8.1 ...

An updated guideline on pharmacotherapy of obesity management in adults includes six new and seven revised recommendations, ...

Both Pfizer Canada and Moderna Canada confirmed to The Canadian Press on Thursday that the U.S. backing away from mRNA vaccines should not affect availability of their updated COVID-19 vaccines in ...

Pfizer's beleaguered obesity strategy has hit another setback as the pharma jettisoned its third and final GLP-1 agonist, citing poor data and tough competition. Pfizer's last remaining GLP-1 ...

Pfizer exceeds analyst expectations with $0.78 EPS and $14.7B revenue in Q2 2025, beating estimates by significant margins despite recent stock struggles.

Pfizer CEO Albert Bourla is expected at a pro-Trump fundraiser on Friday, sources told CBS News, one day after the president sent a letter pushing drug companies to slash prices.

NEW YORK-- (BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) announced today the completion of a global, ex-China, licensing agreement with 3SBio, Inc. (01530.HK) granting Pfizer exclusive rights for the ...

In an exclusive interview, Sally Susman, a pioneer in corporate comms, recounts finding out that Pfizer's COVID-19 vaccine was viable.